enzalutamide
Astellas,Pfizer
['great work', 'crpc']
great to see so much interest in tom westbrook s poster from the lab on transcriptional profiling of matched biopsies after enza in crpc at #asco22! great work tom! hope to get this out soon! 
We study transcriptional regulation and epigenetics in lethal prostate cancer. Our goal is to develop new treatments to improve patient outcomes.